netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 11 of 11


Details
LDL Link Added : MHRA Drug Safety Update (May 2012): Epidermal growth factor receptor (EGFR) inhibitors: serious cases of keratitis and ulcerative keratitis : https://www.gov.uk/drug-safety-update/epidermal-growth-factor-receptor-egfr-inhibitors-serious-cases
04/07/2023 12:01:33
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (September 2013): Panitumumab: treatment of metastatic colorectal cancer : https://www.gov.uk/drug-safety-update/panitumumab-treatment-of-metastatic-colorectal-cancer
04/07/2023 12:01:16
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (September 2012): Panitumumab (Vectibix): risk of necrotising fasciitis : https://www.gov.uk/drug-safety-update/panitumumab-vectibix-risk-of-necrotising-fasciitis
04/07/2023 12:00:45
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (May 2010): Panitumumab (Vectibix): serious hypersensitivity reactions : https://www.gov.uk/drug-safety-update/panitumumab-vectibix-serious-hypersensitivity-reactions
04/07/2023 12:00:32
(rpaylor )
LDL Link Added : MHRA Drug Safety Update (May 2010): Panitumumab (Vectibix): serious hypersensitivity reactions : https://www.gov.uk/drug-safety-update/panitumumab-vectibix-serious-hypersensitivity-reactions
04/07/2023 12:00:14
(rpaylor )
UPD Panitumumab (Vectibix®) updated
09/05/2018 11:29:59
(LoweryM )
UPD Panitumumab (Vectibix®) approved
11/08/2017 15:23:39
(LoweryM )
UPD Panitumumab (Vectibix®) approved
11/08/2017 15:21:53
(LoweryM )
LDL Link Added : NICE TA439 Cetuximab and panitumumab for previously untreated metastatic colorectal cancer : https://www.nice.org.uk/guidance/ta439
09/08/2017 17:26:31
(DavidS )
UPD Panitumumab (Vectibix®) build NICE TA439 APC July 2017
09/08/2017 17:26:09
(DavidS )
UPD Status Changed to | Hidden | Published
22/03/2017 15:10:44
(DavidS )

 

 
netFormulary